Biotechnology
The Biotechnology industry has a total of 591 stocks, with a combined market cap of $1.11 trillion and total revenue of $110.15 billion.
Market Cap
1.11T
Revenue
110.15B
Profits
-39.52B
PE Ratio
n/a
Profit Margin
-35.88%
Dividend Yield
0.04%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 113.44B | 0.76% | 1,599,921 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 79.29B | 3.12% | 642,462 | 14.34B |
| 3 | ARGX | argenx SE | 44.42B | 3.68% | 368,882 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 43.88B | 4.68% | 1,351,804 | 3.71B |
| 5 | INSM | Insmed Incorporated | 35.25B | 6.65% | 3,667,002 | 606.42M |
| 6 | ONC | BeOne Medicines AG | 32.93B | 4.54% | 233,041 | 5.34B |
| 7 | RPRX | Royalty Pharma plc | 27.67B | 3.45% | 3,402,740 | 2.38B |
| 8 | BNTX | BioNTech SE | 21.33B | 4.26% | 856,835 | 3.37B |
| 9 | MRNA | Moderna, Inc. | 20.15B | 5.33% | 8,157,251 | 1.94B |
| 10 | ROIV | Roivant Sciences Ltd. | 19.82B | 4.88% | 6,070,449 | 13.31M |
| 11 | RVMD | Revolution Medicines, Inc. | 19.27B | 4.90% | 3,246,932 | - |
| 12 | INCY | Incyte Corporation | 18.73B | 4.20% | 1,825,754 | 5.14B |
| 13 | GMAB | Genmab A/S | 16.22B | 3.87% | 1,117,934 | 3.72B |
| 14 | SMMT | Summit Therapeutics Inc. | 14.70B | 11.66% | 3,933,443 | - |
| 15 | BBIO | BridgeBio Pharma, Inc. | 14.40B | 7.06% | 2,345,055 | 502.08M |
| 16 | ASND | Ascendis Pharma A/S | 14.04B | 4.75% | 573,446 | 845.52M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.40B | 3.54% | 1,850,836 | 943.71M |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.01B | 3.59% | 505,743 | 958.40M |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 11.64B | 3.22% | 936,201 | 4.27B |
| 20 | EXEL | Exelixis, Inc. | 11.14B | 2.24% | 1,926,902 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.86B | 3.10% | 2,525,928 | 3.22B |
| 22 | PRAX | Praxis Precision Medicines, Inc. | 8.97B | 16.55% | 639,320 | 7.46M |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.78B | 8.76% | 2,059,443 | 1.09B |
| 24 | AXSM | Axsome Therapeutics, Inc. | 8.65B | 5.31% | 676,980 | 638.50M |
| 25 | ABVX | ABIVAX Société Anonyme | 8.55B | 9.70% | 1,547,316 | 5.37M |
| 26 | PCVX | Vaxcyte, Inc. | 8.36B | 5.73% | 1,876,380 | - |
| 27 | TECH | Bio-Techne Corporation | 8.18B | 0.42% | 2,529,232 | 1.22B |
| 28 | CYTK | Cytokinetics, Incorporated | 8.12B | 4.67% | 1,731,461 | 88.04M |
| 29 | NUVL | Nuvalent, Inc. | 8.06B | 5.96% | 1,034,575 | - |
| 30 | IBRX | ImmunityBio, Inc. | 7.92B | 15.17% | 24,124,728 | 113.29M |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.66B | 4.02% | 1,817,876 | 1.40B |
| 32 | KRYS | Krystal Biotech, Inc. | 7.55B | 4.61% | 298,760 | 389.13M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 6.80B | 4.79% | 1,313,872 | 39.21M |
| 34 | ACLX | Arcellx, Inc. | 6.74B | 0.04% | 1,072,314 | 22.29M |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 6.73B | 5.54% | 944,904 | 46.02M |
| 36 | BLTE | Belite Bio, Inc | 6.27B | 6.88% | 224,099 | - |
| 37 | APGE | Apogee Therapeutics, Inc. | 6.22B | 6.92% | 1,423,457 | - |
| 38 | COGT | Cogent Biosciences, Inc. | 6.20B | 8.76% | 4,562,376 | - |
| 39 | TERN | Terns Pharmaceuticals, Inc. | 6.08B | -0.30% | 12,584,885 | - |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.94B | 12.58% | 1,965,617 | 189.76M |
| 41 | CNTA | Centessa Pharmaceuticals plc | 5.80B | 44.02% | 47,746,216 | 15.00M |
| 42 | CGON | CG Oncology, Inc. | 5.71B | 5.82% | 1,945,763 | 4.04M |
| 43 | SRRK | Scholar Rock Holding Corporation | 5.65B | 14.11% | 5,240,097 | - |
| 44 | PTCT | PTC Therapeutics, Inc. | 5.64B | 3.79% | 829,685 | 1.73B |
| 45 | MIRM | Mirum Pharmaceuticals, Inc. | 5.57B | 5.10% | 1,768,328 | 521.31M |
| 46 | XENE | Xenon Pharmaceuticals Inc. | 5.55B | 4.68% | 1,529,567 | 7.50M |
| 47 | CELC | Celcuity Inc. | 5.52B | 5.42% | 521,453 | - |
| 48 | APLS | Apellis Pharmaceuticals, Inc. | 5.14B | 135.40% | 91,087,397 | 1.00B |
| 49 | IMVT | Immunovant, Inc. | 5.06B | 5.48% | 1,819,345 | - |
| 50 | CAI | Caris Life Sciences, Inc. | 5.05B | 6.11% | 3,047,121 | 812.03M |
| 51 | ERAS | Erasca, Inc. | 5.03B | 8.30% | 6,519,762 | - |
| 52 | TGTX | TG Therapeutics, Inc. | 4.91B | 5.43% | 3,175,414 | 616.29M |
| 53 | CRSP | CRISPR Therapeutics AG | 4.57B | 7.28% | 2,167,700 | 3.51M |
| 54 | FOLD | Amicus Therapeutics, Inc. | 4.54B | 0.21% | 2,618,335 | 634.21M |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 4.44B | 5.63% | 2,078,637 | 2.04M |
| 56 | CORT | Corcept Therapeutics Incorporated | 4.29B | 5.75% | 1,509,210 | 761.41M |
| 57 | LGND | Ligand Pharmaceuticals Incorporated | 3.98B | 3.64% | 196,091 | 268.09M |
| 58 | SYRE | Spyre Therapeutics, Inc. | 3.96B | 11.05% | 1,033,850 | - |
| 59 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.80B | 5.98% | 1,386,989 | 7.70M |
| 60 | ACAD | ACADIA Pharmaceuticals Inc. | 3.80B | 5.65% | 2,209,041 | 1.07B |
| 61 | VKTX | Viking Therapeutics, Inc. | 3.76B | 8.76% | 2,732,985 | - |
| 62 | NAMS | NewAmsterdam Pharma Company N.V. | 3.68B | 9.14% | 1,466,424 | 22.50M |
| 63 | GPCR | Structure Therapeutics Inc. | 3.41B | 9.70% | 1,641,530 | - |
| 64 | EWTX | Edgewise Therapeutics, Inc. | 3.38B | 4.03% | 1,072,606 | - |
| 65 | LEGN | Legend Biotech Corporation | 3.35B | 4.51% | 1,224,921 | 1.03B |
| 66 | TLX | Telix Pharmaceuticals Limited | 3.18B | 6.81% | 240,092 | 803.79M |
| 67 | DNLI | Denali Therapeutics Inc. | 3.04B | 6.19% | 2,216,412 | - |
| 68 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.02B | 4.12% | 995,680 | 588.99M |
| 69 | DYN | Dyne Therapeutics, Inc. | 2.99B | 6.09% | 2,205,063 | - |
| 70 | TARS | Tarsus Pharmaceuticals, Inc. | 2.99B | 4.83% | 801,478 | 451.36M |
| 71 | TNGX | Tango Therapeutics, Inc. | 2.99B | 8.90% | 2,966,777 | 62.38M |
| 72 | IDYA | IDEAYA Biosciences, Inc. | 2.93B | 5.95% | 1,173,520 | 218.71M |
| 73 | ARQT | Arcutis Biotherapeutics, Inc. | 2.92B | 10.45% | 2,062,583 | 376.07M |
| 74 | VERA | Vera Therapeutics, Inc. | 2.87B | 5.59% | 1,827,182 | - |
| 75 | ALMS | Alumis Inc. | 2.80B | 9.01% | 2,771,870 | 24.05M |
| 76 | TVTX | Travere Therapeutics, Inc. | 2.74B | 7.41% | 1,832,702 | 490.73M |
| 77 | RCUS | Arcus Biosciences, Inc. | 2.71B | 4.60% | 1,460,498 | 247.00M |
| 78 | IMNM | Immunome, Inc. | 2.47B | 13.32% | 4,209,109 | 6.94M |
| 79 | IRON | Disc Medicine, Inc. | 2.44B | 5.20% | 476,923 | - |
| 80 | ORKA | Oruka Therapeutics, Inc. | 2.43B | 7.75% | 1,028,177 | - |
| 81 | BEAM | Beam Therapeutics Inc. | 2.37B | 8.81% | 2,393,058 | 139.74M |
| 82 | KOD | Kodiak Sciences Inc. | 2.36B | 13.25% | 2,556,282 | - |
| 83 | MANE | Veradermics, Incorporated | 2.36B | 3.78% | 818,693 | - |
| 84 | ELVN | Enliven Therapeutics, Inc. | 2.34B | 7.13% | 1,938,012 | - |
| 85 | SRPT | Sarepta Therapeutics, Inc. | 2.28B | 6.25% | 2,265,316 | 2.20B |
| 86 | MLYS | Mineralys Therapeutics, Inc. | 2.23B | 15.23% | 2,507,993 | - |
| 87 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | 0.09% | 964,819 | 158.18M |
| 88 | AAPG | Ascentage Pharma Group International | 2.16B | 3.11% | 2,249 | 82.08M |
| 89 | ADMA | ADMA Biologics, Inc. | 2.15B | -1.53% | 7,298,874 | 510.17M |
| 90 | ADPT | Adaptive Biotechnologies Corporation | 2.14B | 8.02% | 2,401,488 | 276.98M |
| 91 | ZLAB | Zai Lab Limited | 2.12B | 5.38% | 587,945 | 460.16M |
| 92 | CLDX | Celldex Therapeutics, Inc. | 2.11B | 7.60% | 1,369,463 | 1.55M |
| 93 | NKTR | Nektar Therapeutics | 2.06B | 10.27% | 1,680,402 | 55.23M |
| 94 | TYRA | Tyra Biosciences, Inc. | 2.06B | 10.69% | 1,289,730 | - |
| 95 | SNDX | Syndax Pharmaceuticals, Inc. | 2.06B | 3.91% | 2,725,307 | 172.35M |
| 96 | RARE | Ultragenyx Pharmaceutical Inc. | 2.06B | 8.55% | 2,958,409 | 673.00M |
| 97 | VRDN | Viridian Therapeutics, Inc. | 2.00B | 5.56% | 4,409,057 | 70.85M |
| 98 | GLPG | Galapagos NV | 1.99B | 4.21% | 462,446 | 1.31B |
| 99 | AGIO | Agios Pharmaceuticals, Inc. | 1.98B | 14.25% | 3,606,455 | 54.03M |
| 100 | AUPH | Aurinia Pharmaceuticals Inc. | 1.97B | 6.01% | 1,475,856 | 283.06M |
| 101 | STOK | Stoke Therapeutics, Inc. | 1.93B | 2.49% | 1,057,888 | 184.42M |
| 102 | MESO | Mesoblast Limited | 1.91B | 7.03% | 209,362 | 65.38M |
| 103 | DFTX | Definium Therapeutics, Inc. | 1.88B | 8.00% | 2,316,292 | - |
| 104 | ZYME | Zymeworks Inc. | 1.85B | 3.43% | 576,279 | 105.97M |
| 105 | OCUL | Ocular Therapeutix, Inc. | 1.84B | 14.46% | 5,426,748 | 51.95M |
| 106 | PHVS | Pharvaris N.V. | 1.84B | 3.52% | 563,733 | - |
| 107 | SION | Sionna Therapeutics, Inc. | 1.80B | 9.36% | 569,944 | - |
| 108 | RLAY | Relay Therapeutics, Inc. | 1.78B | 6.42% | 2,178,663 | 15.36M |
| 109 | CAPR | Capricor Therapeutics, Inc. | 1.75B | 9.47% | 1,944,671 | 11.13M |
| 110 | SLNO | Soleno Therapeutics, Inc. | 1.73B | 9.99% | 3,056,613 | 190.41M |
| 111 | INVA | Innoviva, Inc. | 1.73B | 1.70% | 725,797 | 411.33M |
| 112 | PVLA | Palvella Therapeutics, Inc. | 1.67B | 12.64% | 556,313 | - |
| 113 | VCEL | Vericel Corporation | 1.64B | 5.30% | 935,118 | 276.26M |
| 114 | RXRX | Recursion Pharmaceuticals, Inc. | 1.62B | 8.10% | 13,922,446 | 74.68M |
| 115 | HRMY | Harmony Biosciences Holdings, Inc. | 1.62B | 4.13% | 780,014 | 868.45M |
| 116 | NRIX | Nurix Therapeutics, Inc. | 1.60B | 5.66% | 1,669,361 | 83.98M |
| 117 | ANAB | AnaptysBio, Inc. | 1.59B | 0.13% | 808,895 | 234.60M |
| 118 | GENB | Generate Biomedicines, Inc. | 1.59B | 8.60% | 309,538 | 31.89M |
| 119 | OCS | Oculis Holding AG | 1.57B | 8.23% | 306,391 | 1.51M |
| 120 | DMRA | Damora Therapeutics, Inc. | 1.56B | 6.72% | 245,194 | - |
| 121 | TRVI | Trevi Therapeutics, Inc. | 1.53B | 6.61% | 1,016,964 | - |
| 122 | IMCR | Immunocore Holdings plc | 1.53B | 2.94% | 924,873 | 400.02M |
| 123 | NTLA | Intellia Therapeutics, Inc. | 1.51B | 10.04% | 4,200,854 | 67.67M |
| 124 | RAPP | Rapport Therapeutics, Inc. | 1.50B | 13.00% | 459,257 | - |
| 125 | MAZE | Maze Therapeutics, Inc. | 1.48B | 2.90% | 1,736,214 | 2.50M |
| 126 | NUVB | Nuvation Bio Inc. | 1.47B | 5.93% | 4,234,467 | 62.90M |
| 127 | ARDX | Ardelyx, Inc. | 1.47B | 7.93% | 5,472,657 | 407.32M |
| 128 | IOVA | Iovance Biotherapeutics, Inc. | 1.45B | 5.72% | 10,969,593 | 263.50M |
| 129 | NBTX | Nanobiotix S.A. | 1.44B | 0.95% | 69,051 | 11.93M |
| 130 | VIR | Vir Biotechnology, Inc. | 1.43B | 5.91% | 1,972,703 | 68.56M |
| 131 | MBX | MBX Biosciences, Inc. | 1.42B | 10.88% | 522,691 | - |
| 132 | SVRA | Savara Inc. | 1.38B | 8.12% | 1,837,552 | - |
| 133 | PGEN | Precigen, Inc. | 1.37B | 19.08% | 12,564,475 | 9.68M |
| 134 | WVE | Wave Life Sciences Ltd. | 1.36B | 9.52% | 12,258,148 | 42.73M |
| 135 | MLTX | MoonLake Immunotherapeutics | 1.34B | 10.10% | 3,014,843 | - |
| 136 | NVAX | Novavax, Inc. | 1.33B | 0.62% | 5,992,300 | 1.12B |
| 137 | IMTX | Immatics N.V. | 1.32B | 5.86% | 190,064 | 56.67M |
| 138 | GLUE | Monte Rosa Therapeutics, Inc. | 1.32B | 5.92% | 1,644,757 | 123.67M |
| 139 | BCAX | Bicara Therapeutics Inc. | 1.30B | 4.46% | 1,004,287 | - |
| 140 | OLMA | Olema Pharmaceuticals, Inc. | 1.30B | 11.10% | 1,344,277 | - |
| 141 | ATAI | AtaiBeckley Inc. | 1.29B | 4.12% | 3,008,754 | 4.09M |
| 142 | TSHA | Taysha Gene Therapies, Inc. | 1.28B | 9.83% | 3,522,891 | 9.77M |
| 143 | BHVN | Biohaven Ltd. | 1.27B | 4.57% | 5,721,152 | - |
| 144 | ORIC | ORIC Pharmaceuticals, Inc. | 1.27B | 3.94% | 1,848,205 | - |
| 145 | CRVS | Corvus Pharmaceuticals, Inc. | 1.23B | 9.18% | 1,282,241 | - |
| 146 | ZBIO | Zenas BioPharma, Inc. | 1.16B | 7.24% | 2,526,225 | 10.00M |
| 147 | DBVT | DBV Technologies S.A. | 1.16B | 7.26% | 395,226 | 5.64M |
| 148 | PHAR | Pharming Group N.V. | 1.13B | 3.94% | 18,079 | 376.13M |
| 149 | SEPN | Septerna, Inc. | 1.08B | 3.13% | 257,752 | 45.95M |
| 150 | EYPT | EyePoint, Inc. | 1.08B | 8.78% | 1,844,117 | 31.37M |
| 151 | ABCL | AbCellera Biologics Inc. | 1.06B | 6.40% | 2,987,382 | 75.13M |
| 152 | IVA | Inventiva S.A. | 1.05B | 1.28% | 983,155 | 19.93M |
| 153 | KALV | KalVista Pharmaceuticals, Inc. | 1.03B | 9.64% | 1,959,580 | 73.62M |
| 154 | QURE | uniQure N.V. | 1.02B | 11.00% | 1,716,694 | 16.10M |
| 155 | AVBP | ArriVent BioPharma, Inc. | 1.02B | 9.80% | 505,951 | - |
| 156 | CTMX | CytomX Therapeutics, Inc. | 1.02B | 6.58% | 3,813,680 | 76.20M |
| 157 | XERS | Xeris Biopharma Holdings, Inc. | 1.00B | 3.57% | 1,996,915 | 291.85M |
| 158 | INBX | Inhibrx Biosciences, Inc. | 982.03M | 12.27% | 256,697 | 1.30M |
| 159 | GERN | Geron Corporation | 954.41M | 5.67% | 14,404,200 | 183.88M |
| 160 | CMPX | Compass Therapeutics, Inc. | 952.67M | 3.73% | 4,366,981 | 850.00K |
| 161 | AKTS | Aktis Oncology, Inc. | 939.62M | 8.16% | 1,184,227 | 6.50M |
| 162 | MPLT | MapLight Therapeutics, Inc. | 895.01M | 8.66% | 245,847 | - |
| 163 | ANNX | Annexon, Inc. | 889.03M | 11.69% | 4,932,367 | - |
| 164 | XNCR | Xencor, Inc. | 884.46M | 6.26% | 1,066,795 | 125.58M |
| 165 | FTRE | Fortrea Holdings Inc. | 880.77M | 6.20% | 1,315,083 | 2.72B |
| 166 | ABUS | Arbutus Biopharma Corporation | 879.65M | 4.65% | 2,062,903 | 14.08M |
| 167 | PHAT | Phathom Pharmaceuticals, Inc. | 875.45M | 5.51% | 1,212,551 | 175.11M |
| 168 | URGN | UroGen Pharma Ltd. | 875.31M | 5.76% | 684,909 | 109.79M |
| 169 | GHRS | GH Research PLC | 872.13M | 7.90% | 171,458 | - |
| 170 | SGP | SpyGlass Pharma, Inc. | 863.25M | 10.87% | 91,148 | - |
| 171 | CGEM | Cullinan Therapeutics, Inc. | 860.08M | 5.89% | 1,074,910 | - |
| 172 | JANX | Janux Therapeutics, Inc. | 845.56M | 6.68% | 1,131,388 | 10.00M |
| 173 | TBPH | Theravance Biopharma, Inc. | 835.73M | 6.36% | 802,746 | 107.46M |
| 174 | EVMN | Evommune, Inc. | 828.06M | 4.50% | 362,884 | 13.00M |
| 175 | TENX | Tenax Therapeutics, Inc. | 804.30M | 14.13% | 609,206 | - |
| 176 | SPRY | ARS Pharmaceuticals, Inc. | 797.36M | 2.69% | 1,850,402 | 84.28M |
| 177 | SANA | Sana Biotechnology, Inc. | 768.58M | 7.46% | 3,472,550 | - |
| 178 | SLS | SELLAS Life Sciences Group, Inc. | 759.63M | 5.62% | 8,314,096 | - |
| 179 | MNKD | MannKind Corporation | 754.85M | 3.38% | 4,839,217 | 348.97M |
| 180 | OMER | Omeros Corporation | 748.71M | 7.65% | 1,792,811 | - |
| 181 | VOR | Vor Biopharma Inc. | 740.71M | 21.36% | 2,416,154 | - |
| 182 | RLMD | Relmada Therapeutics, Inc. | 730.04M | 9.09% | 2,187,042 | - |
| 183 | MRVI | Maravai LifeSciences Holdings, Inc. | 727.50M | -1.74% | 2,123,759 | 185.74M |
| 184 | ANRO | Alto Neuroscience, Inc. | 718.14M | 12.51% | 744,203 | - |
| 185 | KURA | Kura Oncology, Inc. | 718.12M | 5.17% | 1,392,687 | 67.48M |
| 186 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 716.29M | 3.11% | 196,090 | - |
| 187 | DRUG | Bright Minds Biosciences Inc. | 710.76M | 6.60% | 206,318 | - |
| 188 | SLDB | Solid Biosciences Inc. | 708.42M | 10.94% | 2,022,889 | - |
| 189 | MGTX | MeiraGTx Holdings plc | 705.32M | 7.05% | 1,525,990 | 81.39M |
| 190 | JBIO | Jade Biosciences, Inc. | 692.89M | 5.96% | 724,870 | - |
| 191 | ARVN | Arvinas, Inc. | 677.99M | 4.13% | 1,142,411 | 262.60M |
| 192 | LXRX | Lexicon Pharmaceuticals, Inc. | 660.94M | 3.31% | 1,754,606 | 49.80M |
| 193 | DSGN | Design Therapeutics, Inc. | 656.19M | 2.60% | 267,628 | - |
| 194 | GYRE | Gyre Therapeutics, Inc. | 636.46M | 1.75% | 97,641 | 116.59M |
| 195 | REPL | Replimune Group, Inc. | 631.68M | 6.25% | 2,130,356 | - |
| 196 | LBRX | LB Pharmaceuticals Inc | 623.88M | 6.06% | 312,959 | - |
| 197 | DRTS | Alpha Tau Medical Ltd. | 622.23M | 7.94% | 210,765 | - |
| 198 | PRME | Prime Medicine, Inc. | 616.24M | 10.48% | 2,034,738 | 4.63M |
| 199 | OCGN | Ocugen, Inc. | 611.59M | 3.43% | 7,512,286 | 4.41M |
| 200 | CBIO | Crescent Biopharma, Inc. | 610.14M | 10.53% | 197,084 | 10.84M |
| 201 | ALLO | Allogene Therapeutics, Inc. | 594.82M | 9.91% | 3,680,161 | 22.00K |
| 202 | MDXG | MiMedx Group, Inc. | 586.84M | 2.33% | 1,575,236 | 418.63M |
| 203 | TECX | Tectonic Therapeutic, Inc. | 580.39M | 7.07% | 150,049 | - |
| 204 | EIKN | Eikon Therapeutics, Inc. | 571.15M | 9.30% | 474,348 | - |
| 205 | VALN | Valneva SE | 564.95M | 0.97% | 363,947 | 205.07M |
| 206 | ZURA | Zura Bio Limited | 564.54M | 4.75% | 626,666 | - |
| 207 | ZVRA | Zevra Therapeutics, Inc. | 547.19M | 6.15% | 923,051 | 106.47M |
| 208 | YDES | YD Bio Limited | 541.46M | -4.94% | 14,426 | 510.36K |
| 209 | PROK | ProKidney Corp. | 540.43M | 10.49% | 1,352,041 | 893.00K |
| 210 | CRMD | CorMedix Inc. | 536.75M | 3.35% | 1,237,301 | 311.71M |
| 211 | PRTA | Prothena Corporation plc | 523.26M | 5.08% | 671,508 | 9.68M |
| 212 | KYTX | Kyverna Therapeutics, Inc. | 521.73M | 13.85% | 909,027 | - |
| 213 | ACRS | Aclaris Therapeutics, Inc. | 521.23M | 7.45% | 2,089,190 | 7.83M |
| 214 | AGMB | AgomAb Therapeutics NV | 511.25M | 6.39% | 495,001 | - |
| 215 | FULC | Fulcrum Therapeutics, Inc. | 510.82M | 16.57% | 4,644,367 | 80.00M |
| 216 | RIGL | Rigel Pharmaceuticals, Inc. | 499.51M | 5.13% | 208,912 | 294.28M |
| 217 | VTVT | vTv Therapeutics Inc. | 492.16M | 10.00% | 53,485 | 17.00K |
| 218 | NAUT | Nautilus Biotechnology, Inc. | 491.07M | 13.12% | 387,775 | - |
| 219 | UPB | Upstream Bio, Inc. | 489.78M | 2.51% | 967,170 | 2.85M |
| 220 | CTNM | Contineum Therapeutics, Inc. | 487.61M | 4.82% | 430,095 | - |
| 221 | IMMX | Immix Biopharma, Inc. | 482.51M | 6.18% | 1,221,121 | - |
| 222 | ADCT | ADC Therapeutics SA | 476.42M | 3.02% | 919,138 | 81.36M |
| 223 | FDMT | 4D Molecular Therapeutics, Inc. | 475.29M | 8.63% | 705,068 | 85.21M |
| 224 | LYEL | Lyell Immunopharma, Inc. | 471.97M | 4.98% | 112,467 | 36.00K |
| 225 | LRMR | Larimar Therapeutics, Inc. | 467.47M | 4.41% | 1,750,460 | - |
| 226 | VSTM | Verastem, Inc. | 465.53M | 9.28% | 3,537,643 | 30.91M |
| 227 | FBRX | Forte Biosciences, Inc. | 461.83M | -1.60% | 267,593 | - |
| 228 | STTK | Shattuck Labs, Inc. | 460.16M | 7.89% | 511,867 | 1.00M |
| 229 | ABSI | Absci Corporation | 459.06M | 8.70% | 3,793,120 | 2.80M |
| 230 | ENGN | enGene Holdings Inc. | 456.20M | 10.19% | 243,159 | - |
| 231 | TRDA | Entrada Therapeutics, Inc. | 454.32M | 7.22% | 257,744 | 25.42M |
| 232 | EPRX | Eupraxia Pharmaceuticals Inc. | 442.37M | 9.53% | 141,071 | - |
| 233 | ASMB | Assembly Biosciences, Inc. | 440.19M | 4.24% | 97,583 | 72.30M |
| 234 | RGNX | REGENXBIO Inc. | 432.52M | 7.85% | 566,686 | 170.44M |
| 235 | AURA | Aura Biosciences, Inc. | 429.17M | 7.90% | 340,141 | - |
| 236 | AVIR | Atea Pharmaceuticals, Inc. | 428.64M | 5.91% | 325,168 | - |
| 237 | LXEO | Lexeo Therapeutics, Inc. | 425.26M | 8.92% | 1,390,306 | - |
| 238 | STRO | Sutro Biopharma, Inc. | 412.69M | 3.36% | 102,863 | 102.48M |
| 239 | VNDA | Vanda Pharmaceuticals Inc. | 408.44M | 3.91% | 1,451,959 | 216.11M |
| 240 | IPSC | Century Therapeutics, Inc. | 406.17M | 11.33% | 924,729 | 109.16M |
| 241 | ALT | Altimmune, Inc. | 400.72M | 6.94% | 3,287,003 | 41.00K |
| 242 | LCTX | Lineage Cell Therapeutics, Inc. | 393.56M | 7.48% | 1,022,328 | 14.56M |
| 243 | RCKT | Rocket Pharmaceuticals, Inc. | 388.68M | 3.92% | 4,467,212 | - |
| 244 | XFOR | X4 Pharmaceuticals, Inc. | 375.50M | 3.51% | 371,226 | 35.11M |
| 245 | ARMP | Armata Pharmaceuticals, Inc. | 375.12M | 19.21% | 21,226 | 4.90M |
| 246 | XOMA | XOMA Royalty Corporation | 374.03M | 3.77% | 122,556 | 52.15M |
| 247 | IVVD | Invivyd, Inc. | 367.37M | 9.24% | 4,064,547 | 53.43M |
| 248 | AUTL | Autolus Therapeutics plc | 367.28M | 8.66% | 3,451,434 | 75.39M |
| 249 | MNPR | Monopar Therapeutics Inc. | 366.74M | 2.98% | 171,813 | - |
| 250 | ENTA | Enanta Pharmaceuticals, Inc. | 366.51M | 3.69% | 107,453 | 66.98M |
| 251 | BNTC | Benitec Biopharma Inc. | 364.81M | 5.86% | 136,114 | - |
| 252 | DMAC | DiaMedica Therapeutics Inc. | 364.78M | 1.96% | 387,909 | - |
| 253 | CADL | Candel Therapeutics, Inc. | 358.91M | 9.37% | 1,387,762 | - |
| 254 | PLYX | Polaryx Therapeutics, Inc. | 357.92M | 14.37% | 417,473 | - |
| 255 | DNA | Ginkgo Bioworks Holdings, Inc. | 356.81M | 11.86% | 1,234,051 | 170.16M |
| 256 | NAGE | Niagen Bioscience, Inc. | 353.89M | 3.04% | 723,503 | 129.42M |
| 257 | PRTC | PureTech Health plc | 346.64M | 2.48% | 2,936 | 6.39M |
| 258 | IMRX | Immuneering Corporation | 340.72M | 7.99% | 541,513 | - |
| 259 | AVTX | Avalo Therapeutics, Inc. | 340.23M | 7.18% | 1,047,525 | 59.00K |
| 260 | SRZN | Surrozen, Inc. | 334.61M | 6.12% | 180,872 | 3.48M |
| 261 | GLSI | Greenwich LifeSciences, Inc. | 332.79M | 11.77% | 166,836 | - |
| 262 | NMRA | Neumora Therapeutics, Inc. | 331.38M | 1.04% | 3,155,732 | - |
| 263 | CLYM | Climb Bio, Inc. | 327.21M | 4.74% | 289,450 | - |
| 264 | PBYI | Puma Biotechnology, Inc. | 325.10M | 4.24% | 253,331 | 228.37M |
| 265 | IRD | Opus Genetics, Inc. | 323.73M | 4.60% | 443,447 | 14.20M |
| 266 | BCYC | Bicycle Therapeutics plc | 323.44M | 6.91% | 300,852 | 72.59M |
| 267 | RZLT | Rezolute, Inc. | 316.81M | 7.02% | 1,954,284 | - |
| 268 | NGNE | Neurogene Inc. | 313.98M | 4.46% | 92,660 | 925.00K |
| 269 | NGEN | NervGen Pharma Corp. | 300.28M | 1.07% | 157,308 | - |
| 270 | CABA | Cabaletta Bio, Inc. | 299.46M | 8.91% | 1,785,944 | - |
| 271 | OVID | Ovid Therapeutics Inc. | 292.76M | 5.21% | 2,769,022 | 7.25M |
| 272 | PALI | Palisade Bio, Inc. | 290.30M | -1.69% | 14,974,434 | - |
| 273 | LENZ | LENZ Therapeutics, Inc. | 286.89M | 10.37% | 2,005,201 | 19.09M |
| 274 | IKT | Inhibikase Therapeutics, Inc. | 286.31M | 6.33% | 647,077 | 1.00 |
| 275 | AVXL | Anavex Life Sciences Corp. | 284.50M | 8.87% | 1,868,036 | - |
| 276 | NBP | NovaBridge Biosciences | 283.62M | 9.82% | 1,023,929 | - |
| 277 | PRLD | Prelude Therapeutics Incorporated | 282.27M | 11.40% | 188,539 | 12.14M |
| 278 | TARA | Protara Therapeutics, Inc. | 281.78M | 7.42% | 436,550 | - |
| 279 | FHTX | Foghorn Therapeutics Inc. | 280.59M | 8.14% | 144,069 | 30.91M |
| 280 | ACIU | AC Immune SA | 272.80M | 7.42% | 127,559 | 4.51M |
| 281 | SABS | SAB Biotherapeutics, Inc. | 269.16M | 1.32% | 456,581 | 114.70K |
| 282 | ALXO | ALX Oncology Holdings Inc. | 263.87M | 4.97% | 384,513 | - |
| 283 | NERV | Minerva Neurosciences, Inc. | 260.73M | 0.92% | 167,289 | - |
| 284 | SLGL | Sol-Gel Technologies Ltd. | 259.23M | 15.70% | 68,233 | 19.39M |
| 285 | CCCC | C4 Therapeutics, Inc. | 256.63M | 11.91% | 2,060,853 | 35.95M |
| 286 | ABEO | Abeona Therapeutics Inc. | 255.58M | 5.91% | 1,097,393 | 5.82M |
| 287 | ANL | Adlai Nortye Ltd. | 255.35M | 4.69% | 346,761 | -1.35M |
| 288 | CHRS | Coherus Oncology, Inc. | 253.31M | 5.62% | 865,367 | 42.17M |
| 289 | OBIO | Orchestra BioMed Holdings, Inc. | 248.71M | 4.42% | 89,160 | 33.48M |
| 290 | SLN | Silence Therapeutics plc | 247.98M | 5.42% | 394,325 | 559.00K |
| 291 | EDIT | Editas Medicine, Inc. | 241.74M | 10.76% | 1,882,645 | 40.52M |
| 292 | CNTX | Context Therapeutics Inc. | 240.72M | 6.94% | 391,355 | - |
| 293 | HELP | Cybin Inc. | 240.17M | 11.11% | 756,533 | - |
| 294 | CLLS | Cellectis S.A. | 237.28M | - | 43,882 | 79.59M |
| 295 | ALEC | Alector, Inc. | 237.28M | 6.44% | 352,528 | 21.05M |
| 296 | ELDN | Eledon Pharmaceuticals, Inc. | 233.98M | 13.65% | 1,912,080 | - |
| 297 | AKTX | Akari Therapeutics, Plc | 233.13M | 6.40% | 28,053 | - |
| 298 | VYGR | Voyager Therapeutics, Inc. | 230.05M | -0.26% | 496,003 | 40.37M |
| 299 | CAMP | Camp4 Therapeutics Corporation | 228.96M | 10.25% | 102,437 | 3.50M |
| 300 | OABI | OmniAb, Inc. | 227.31M | 0.64% | 285,310 | 18.67M |
| 301 | ENLV | Enlivex Ltd. | 220.79M | 3.34% | 337,301 | - |
| 302 | ARCT | Arcturus Therapeutics Holdings Inc. | 219.43M | 11.88% | 914,128 | 82.03M |
| 303 | KROS | Keros Therapeutics, Inc. | 217.48M | 3.28% | 454,616 | 244.06M |
| 304 | FENC | Fennec Pharmaceuticals Inc. | 212.02M | 6.59% | 119,496 | 44.64M |
| 305 | MDWD | MediWound Ltd. | 206.94M | 4.20% | 72,382 | 16.96M |
| 306 | NVCT | Nuvectis Pharma, Inc. | 204.78M | 3.20% | 43,264 | - |
| 307 | CGEN | Compugen Ltd. | 201.40M | 7.04% | 266,749 | 72.76M |
| 308 | ELTX | Elicio Therapeutics, Inc. | 196.65M | 6.05% | 98,011 | - |
| 309 | TNXP | Tonix Pharmaceuticals Holding Corp. | 195.32M | 14.30% | 499,861 | 13.11M |
| 310 | ADAG | Adagene Inc. | 184.75M | 3.43% | 56,484 | 103.20K |
| 311 | MGNX | MacroGenics, Inc. | 183.68M | 4.71% | 281,697 | 149.50M |
| 312 | CRBU | Caribou Biosciences, Inc. | 183.61M | 10.47% | 1,605,510 | 11.16M |
| 313 | GALT | Galectin Therapeutics Inc. | 179.88M | 8.56% | 214,847 | - |
| 314 | PLX | Protalix BioTherapeutics, Inc. | 174.84M | 3.83% | 966,912 | 52.74M |
| 315 | PRQR | ProQR Therapeutics N.V. | 170.68M | 7.28% | 699,337 | 19.19M |
| 316 | ABOS | Acumen Pharmaceuticals, Inc. | 170.42M | 7.76% | 413,002 | - |
| 317 | SGMT | Sagimet Biosciences Inc. | 170.26M | 14.84% | 383,612 | - |
| 318 | CNTN | Canton Strategic Holdings, Inc. | 168.47M | 6.17% | 746,449 | - |
| 319 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 166.55M | 9.19% | 334,339 | - |
| 320 | MENS | Jyong Biotech Ltd. | 165.34M | 13.16% | 217,495 | - |
| 321 | KRRO | Korro Bio, Inc. | 163.26M | 10.12% | 311,564 | 6.39M |
| 322 | RNAC | Cartesian Therapeutics, Inc. | 163.03M | 4.59% | 153,477 | 2.80M |
| 323 | WHWK | Whitehawk Therapeutics, Inc. | 162.83M | 5.18% | 291,903 | 7.15M |
| 324 | ARTV | Artiva Biotherapeutics, Inc. | 159.18M | 18.17% | 197,192 | 251.00K |
| 325 | ACHV | Achieve Life Sciences, Inc. | 156.53M | 10.11% | 1,002,437 | - |
| 326 | ZNTL | Zentalis Pharmaceuticals, Inc. | 151.52M | 9.35% | 466,225 | 26.87M |
| 327 | HRTX | Heron Therapeutics, Inc. | 150.85M | 7.27% | 1,238,232 | 154.90M |
| 328 | CBUS | Cibus, Inc. | 150.82M | 8.79% | 600,794 | 3.64M |
| 329 | NKTX | Nkarta, Inc. | 150.42M | 5.50% | 444,150 | - |
| 330 | TNYA | Tenaya Therapeutics, Inc. | 150.25M | 11.68% | 2,472,849 | - |
| 331 | TLSA | Tiziana Life Sciences Ltd | 149.32M | -5.65% | 227,694 | - |
| 332 | CDXS | Codexis, Inc. | 148.12M | 7.24% | 898,564 | 70.39M |
| 333 | CNTB | Connect Biopharma Holdings Limited | 146.47M | -9.66% | 418,098 | 762.00K |
| 334 | MIST | Milestone Pharmaceuticals Inc. | 145.95M | 17.82% | 4,488,705 | 1.55M |
| 335 | MOLN | Molecular Partners AG | 145.52M | 0.99% | 1,728 | 856.30K |
| 336 | IMUX | Immunic, Inc. | 144.82M | 7.77% | 1,637,553 | - |
| 337 | DTIL | Precision BioSciences, Inc. | 142.43M | 1.85% | 152,323 | 34.26M |
| 338 | UNCY | Unicycive Therapeutics, Inc. | 141.41M | 7.69% | 566,801 | - |
| 339 | NTHI | NeOnc Technologies Holdings, Inc. | 140.31M | 0.14% | 42,193 | 59.99K |
| 340 | FATE | Fate Therapeutics, Inc. | 139.52M | 6.19% | 1,496,982 | 6.65M |
| 341 | SPRO | Spero Therapeutics, Inc. | 135.47M | 4.46% | 485,409 | 66.80M |
| 342 | ORMP | Oramed Pharmaceuticals Inc. | 135.33M | 4.27% | 64,184 | 2.00M |
| 343 | HUMA | Humacyte, Inc. | 134.70M | 5.60% | 7,097,110 | 2.04M |
| 344 | KLRS | Kalaris Therapeutics, Inc. | 132.30M | 8.87% | 58,277 | - |
| 345 | AGEN | Agenus Inc. | 128.25M | 3.09% | 394,449 | 114.20M |
| 346 | EQ | Equillium, Inc. | 126.45M | 14.29% | 344,308 | 4.39M |
| 347 | KPTI | Karyopharm Therapeutics Inc. | 125.57M | 5.09% | 505,497 | 146.07M |
| 348 | ANTX | AN2 Therapeutics, Inc. | 122.92M | -1.16% | 238,394 | - |
| 349 | PEPG | PepGen Inc. | 122.33M | -58.16% | 26,690,784 | - |
| 350 | BDTX | Black Diamond Therapeutics, Inc. | 122.03M | 4.93% | 592,119 | 70.00M |
| 351 | INO | Inovio Pharmaceuticals, Inc. | 120.22M | 4.19% | 802,404 | 65.34K |
| 352 | ACOG | Alpha Cognition Inc. | 119.36M | 3.20% | 306,071 | 10.22M |
| 353 | IPHA | Innate Pharma S.A. | 114.12M | 1.59% | 10,964 | 10.57M |
| 354 | PMN | ProMIS Neurosciences, Inc. | 113.89M | -1.40% | 40,113 | - |
| 355 | CRDF | Cardiff Oncology, Inc. | 110.75M | 4.52% | 596,103 | 593.00K |
| 356 | BMEA | Biomea Fusion, Inc. | 110.62M | 15.91% | 3,899,392 | - |
| 357 | HURA | TuHURA Biosciences, Inc. | 108.69M | 3.47% | 265,338 | - |
| 358 | GNLX | Genelux Corporation | 107.38M | 5.22% | 137,888 | 8.00K |
| 359 | ALDX | Aldeyra Therapeutics, Inc. | 101.71M | 0.60% | 2,390,506 | - |
| 360 | LONA | LeonaBio, Inc. | 95.97M | 10.90% | 24,707 | - |
| 361 | SEER | Seer, Inc. | 94.79M | - | 141,278 | 16.58M |
| 362 | TTRX | Turn Therapeutics Inc. | 94.22M | -0.62% | 12,647 | - |
| 363 | QTTB | Q32 Bio Inc. | 93.92M | 8.81% | 232,140 | 53.74M |
| 364 | COYA | Coya Therapeutics, Inc. | 92.19M | 3.97% | 99,373 | 7.95M |
| 365 | SGMO | Sangamo Therapeutics, Inc. | 91.77M | -19.66% | 24,723,687 | 39.55M |
| 366 | PYXS | Pyxis Oncology, Inc. | 91.73M | 14.96% | 356,993 | 13.86M |
| 367 | ONCY | Oncolytics Biotech Inc. | 91.34M | 5.44% | 636,175 | - |
| 368 | VRCA | Verrica Pharmaceuticals Inc. | 90.88M | 11.13% | 65,310 | 35.58M |
| 369 | SPRB | Spruce Biosciences, Inc. | 89.66M | 11.65% | 22,439 | 697.00K |
| 370 | FBIO | Fortress Biotech, Inc. | 86.60M | 3.33% | 700,666 | 62.30M |
| 371 | ANIX | Anixa Biosciences, Inc. | 86.50M | 3.20% | 134,494 | - |
| 372 | MCRB | Seres Therapeutics, Inc. | 85.03M | 0.80% | 9,801 | 789.00K |
| 373 | KZIA | Kazia Therapeutics Limited | 85.02M | 1.78% | 378,998 | 1.27M |
| 374 | MAIA | MAIA Biotechnology, Inc. | 84.94M | 6.87% | 1,032,082 | - |
| 375 | VANI | Vivani Medical, Inc. | 84.65M | 6.61% | 254,451 | - |
| 376 | OKYO | OKYO Pharma Limited | 84.49M | 6.62% | 86,154 | - |
| 377 | PYPD | PolyPid Ltd. | 83.58M | 4.04% | 100,546 | - |
| 378 | NRXS | NeurAxis, Inc. | 82.79M | 11.95% | 119,338 | 3.57M |
| 379 | AARD | Aardvark Therapeutics, Inc. | 82.25M | 3.57% | 389,173 | - |
| 380 | GANX | Gain Therapeutics, Inc. | 81.95M | 7.78% | 359,611 | - |
| 381 | FLNA | Filana Therapeutics, Inc. | 81.64M | 4.32% | 343,763 | - |
| 382 | CSBR | Champions Oncology, Inc. | 81.10M | - | 2,755 | 57.95M |
| 383 | PLRX | Pliant Therapeutics, Inc. | 78.01M | 7.23% | 1,150,694 | - |
| 384 | GOSS | Gossamer Bio, Inc. | 77.10M | 2.66% | 7,194,796 | 48.47M |
| 385 | ATYR | aTyr Pharma, Inc. | 76.48M | 6.72% | 1,033,827 | 190.00K |
| 386 | RANI | Rani Therapeutics Holdings, Inc. | 73.28M | -3.71% | 2,317,284 | 1.63M |
| 387 | ACET | Adicet Bio, Inc. | 73.20M | 11.46% | 71,811 | - |
| 388 | GUTS | Fractyl Health, Inc. | 72.63M | 7.21% | 2,098,370 | 3.00K |
| 389 | CING | Cingulate Inc. | 72.21M | 6.34% | 371,272 | - |
| 390 | XBIT | XBiotech Inc. | 71.65M | 3.96% | 40,698 | - |
| 391 | GRCE | Grace Therapeutics, Inc. | 71.64M | 6.19% | 539,239 | - |
| 392 | BYSI | BeyondSpring Inc. | 70.73M | 6.17% | 2,651 | 1.88M |
| 393 | PTHS | Pelthos Therapeutics Inc. | 70.50M | 0.05% | 3,181 | 16.80M |
| 394 | DWTX | Dogwood Therapeutics, Inc. | 70.48M | 18.54% | 61,911 | - |
| 395 | NRXP | NRx Pharmaceuticals, Inc. | 70.36M | 1.91% | 439,822 | 1.23M |
| 396 | COEP | Coeptis Therapeutics Holdings, Inc. | 69.82M | 4.66% | 16,185 | 1.36M |
| 397 | CGTX | Cognition Therapeutics, Inc. | 67.86M | 27.73% | 2,239,894 | - |
| 398 | MNOV | MediciNova, Inc. | 67.43M | 0.74% | 30,876 | 409.66K |
| 399 | ATHE | Alterity Therapeutics Limited | 67.18M | -2.52% | 4,449 | 4.43M |
| 400 | PMVP | PMV Pharmaceuticals, Inc. | 66.13M | 1.64% | 245,548 | - |
| 401 | IBIO | iBio, Inc. | 65.63M | 11.11% | 802,923 | 300.00K |
| 402 | ACTU | Actuate Therapeutics, Inc. | 64.97M | 19.65% | 112,014 | - |
| 403 | IBO | Impact BioMedical Inc. | 64.69M | 2.49% | 196,470 | 32.00K |
| 404 | IFRX | InflaRx N.V. | 64.66M | 7.54% | 171,596 | 34.44K |
| 405 | ANVS | Annovis Bio, Inc. | 63.23M | 10.95% | 467,479 | - |
| 406 | EXOZ | eXoZymes, Inc. | 63.09M | 2.88% | 5,698 | -700.00 |
| 407 | LPCN | Lipocine Inc. | 58.32M | 5.41% | 142,538 | 1.98M |
| 408 | ICCC | ImmuCell Corporation | 57.80M | -0.62% | 23,703 | 27.64M |
| 409 | TCRX | TScan Therapeutics, Inc. | 57.47M | 7.41% | 224,157 | 10.33M |
| 410 | OKUR | OnKure Therapeutics, Inc. | 56.61M | 9.23% | 424,038 | - |
| 411 | HYFT | MindWalk Holdings Corp. | 56.12M | 10.78% | 190,728 | 20.70M |
| 412 | TIL | Instil Bio, Inc. | 56.02M | 3.64% | 24,208 | - |
| 413 | IMA | ImageneBio, Inc. | 55.92M | - | 48,980 | 800.00K |
| 414 | KZR | Kezar Life Sciences, Inc. | 54.70M | -0.40% | 107,479 | - |
| 415 | ACRV | Acrivon Therapeutics, Inc. | 53.85M | 7.75% | 344,435 | - |
| 416 | MREO | Mereo BioPharma Group plc | 52.67M | 4.43% | 1,547,878 | 500.00K |
| 417 | ENTX | Entera Bio Ltd. | 51.75M | 11.00% | 76,466 | 42.00K |
| 418 | RADX | Radiopharm Theranostics Limited | 50.98M | -0.92% | 35,083 | 10.86M |
| 419 | MGX | Metagenomi Therapeutics, Inc. | 50.41M | 5.93% | 205,967 | 25.21M |
| 420 | OSTX | OS Therapies Incorporated | 49.65M | 6.02% | 533,526 | - |
| 421 | INKT | MiNK Therapeutics, Inc. | 49.43M | 0.10% | 84,240 | - |
| 422 | XLO | Xilio Therapeutics, Inc. | 48.63M | 2.06% | 71,374 | 43.77M |
| 423 | RLYB | Rallybio Corporation | 47.45M | 11.57% | 153,726 | 858.00K |
| 424 | IMMP | Immutep Limited | 47.44M | 0.29% | 725,061 | 5.28M |
| 425 | ALGS | Aligos Therapeutics, Inc. | 45.98M | 13.26% | 54,537 | 2.19M |
| 426 | RNXT | RenovoRx, Inc. | 45.54M | -5.61% | 672,536 | 1.12M |
| 427 | ATOS | Atossa Therapeutics, Inc. | 45.30M | 11.68% | 42,647 | - |
| 428 | LSTA | Lisata Therapeutics, Inc. | 45.25M | 0.20% | 29,584 | 170.00K |
| 429 | ESLA | Estrella Immunopharma, Inc. | 45.23M | 2.91% | 12,847 | - |
| 430 | NTRB | Nutriband Inc. | 44.79M | 6.50% | 9,053 | 2.28M |
| 431 | TELO | Telomir Pharmaceuticals, Inc. | 44.70M | 14.04% | 110,487 | - |
| 432 | EDSA | Edesa Biotech, Inc. | 43.66M | -1.88% | 224,573 | - |
| 433 | LITS | Lite Strategy, Inc. | 42.18M | 11.54% | 503,745 | - |
| 434 | HOWL | Werewolf Therapeutics, Inc. | 40.46M | 4.48% | 340,793 | 1.14M |
| 435 | SNSE | Sensei Biotherapeutics, Inc. | 39.89M | 25.43% | 109,921 | - |
| 436 | NBY | NovaBay Pharmaceuticals, Inc. | 39.67M | 10.37% | 250,579 | 10.30M |
| 437 | ATRA | Atara Biotherapeutics, Inc. | 38.68M | 9.49% | 63,333 | 120.77M |
| 438 | CELU | Celularity Inc. | 38.35M | 5.56% | 64,386 | 40.58M |
| 439 | NXTC | NextCure, Inc. | 38.03M | 7.88% | 35,851 | - |
| 440 | PTN | Palatin Technologies, Inc. | 36.77M | -6.09% | 9,558 | 8.96M |
| 441 | CRVO | CervoMed Inc. | 36.47M | 8.80% | 26,537 | 4.01M |
| 442 | RNTX | Rein Therapeutics Inc. | 36.45M | 2.36% | 31,945 | - |
| 443 | VERU | Veru Inc. | 35.47M | 3.76% | 36,459 | 16.89M |
| 444 | PLUR | Pluri Inc. | 34.12M | 2.26% | 646 | 1.34M |
| 445 | APLM | Apollomics, Inc. | 34.03M | -5.09% | 3,556 | 6.93M |
| 446 | PDSB | PDS Biotechnology Corporation | 33.11M | 12.77% | 841,287 | - |
| 447 | ATNM | Actinium Pharmaceuticals, Inc. | 31.05M | 0.54% | 174,316 | 90.00K |
| 448 | EVAX | Evaxion A/S | 31.03M | -1.33% | 20,388 | 7.53M |
| 449 | HYPD | Hyperion DeFi, Inc. | 30.98M | 7.81% | 148,487 | 813.46K |
| 450 | LGVN | Longeveron Inc. | 30.45M | 11.78% | 556,322 | 1.20M |
| 451 | DYAI | Dyadic International, Inc. | 30.24M | 13.71% | 246,157 | 3.09M |
| 452 | INMB | INmune Bio Inc. | 30.04M | -0.88% | 464,006 | 50.00K |
| 453 | TVRD | Tvardi Therapeutics, Inc. | 29.83M | -0.63% | 41,151 | - |
| 454 | BCTX | BriaCell Therapeutics Corp. | 29.37M | 1.45% | 127,864 | - |
| 455 | PSTV | Plus Therapeutics, Inc. | 27.89M | -24.23% | 25,558,334 | 5.21M |
| 456 | KYNB | Kyntra Bio, Inc. | 27.44M | 4.18% | 23,867 | 6.44M |
| 457 | XCUR | Exicure, Inc. | 27.12M | -4.88% | 9,908 | 500.00K |
| 458 | LIXT | Lixte Biotechnology Holdings, Inc. | 26.75M | -1.92% | 25,671 | - |
| 459 | DARE | Daré Bioscience, Inc. | 26.50M | -0.55% | 70,273 | 1.03M |
| 460 | CVM | CEL-SCI Corporation | 25.98M | 4.56% | 23,295 | - |
| 461 | SNTI | Senti Biosciences, Inc. | 25.29M | 5.21% | 95,798 | 22.00K |
| 462 | NRSN | NeuroSense Therapeutics Ltd. | 25.21M | 3.28% | 3,523 | - |
| 463 | IGC | IGC Pharma, Inc. | 25.20M | 2.94% | 159,449 | 1.11M |
| 464 | PASG | Passage Bio, Inc. | 25.18M | 27.02% | 75,570 | - |
| 465 | AEON | AEON Biopharma, Inc. | 24.92M | -0.45% | 59,150 | - |
| 466 | BOLD | Boundless Bio, Inc. | 24.87M | 2.30% | 173,637 | - |
| 467 | JSPR | Jasper Therapeutics, Inc. | 24.52M | -2.64% | 663,608 | - |
| 468 | QNTM | Quantum BioPharma Ltd. | 24.47M | 12.85% | 414,939 | - |
| 469 | ABVC | ABVC BioPharma, Inc. | 23.97M | 6.67% | 81,132 | 797.92K |
| 470 | SER | Serina Therapeutics, Inc. | 23.89M | 7.78% | 968,348 | 130.00K |
| 471 | TPST | Tempest Therapeutics, Inc. | 23.52M | 7.89% | 176,179 | - |
| 472 | BRNS | Barinthus Biotherapeutics plc | 23.24M | 3.45% | 3,601 | 14.97M |
| 473 | VTGN | Vistagen Therapeutics, Inc. | 22.64M | 4.73% | 305,366 | 789.00K |
| 474 | CUE | Cue Biopharma, Inc. | 22.45M | 1.73% | 570,832 | 27.47M |
| 475 | NEUP | Neuphoria Therapeutics Inc. | 21.94M | 3.81% | 57,300 | 14.99M |
| 476 | CRIS | Curis, Inc. | 21.88M | 6.81% | 322,622 | 9.44M |
| 477 | MRKR | Marker Therapeutics, Inc. | 21.68M | 4.84% | 68,069 | 3.55M |
| 478 | OTLK | Outlook Therapeutics, Inc. | 21.53M | 2.39% | 2,805,768 | 205.70K |
| 479 | SKYE | Skye Bioscience, Inc. | 20.51M | 3.71% | 135,534 | - |
| 480 | CTXR | Citius Pharmaceuticals, Inc. | 20.14M | 32.28% | 1,970,864 | 3.94M |
| 481 | VYNE | VYNE Therapeutics Inc. | 19.93M | 1.69% | 148,499 | 570.00K |
| 482 | NNVC | NanoViricides, Inc. | 19.70M | 4.84% | 66,513 | - |
| 483 | LEXX | Lexaria Bioscience Corp. | 19.41M | - | 114,714 | 522.00K |
| 484 | PLRZ | Polyrizon Ltd. | 18.62M | -1.68% | 46,067 | - |
| 485 | TVGN | Tevogen Bio Holdings Inc. | 18.30M | 5.36% | 36,873 | - |
| 486 | ALLR | Allarity Therapeutics, Inc. | 17.53M | 4.81% | 83,613 | 320.00K |
| 487 | KTTA | Pasithea Therapeutics Corp. | 17.19M | 4.11% | 94,358 | - |
| 488 | GNTA | Genenta Science S.p.A. | 15.74M | 6.65% | 91,752 | - |
| 489 | OSRH | OSR Holdings, Inc. | 15.48M | 13.99% | 1,850,736 | -90.52K |
| 490 | LTRN | Lantern Pharma Inc. | 15.36M | 10.93% | 14,881,659 | - |
| 491 | INTS | Intensity Therapeutics, Inc. | 14.94M | 3.52% | 20,938 | - |
| 492 | TRAW | Traws Pharma, Inc. | 14.90M | 6.58% | 39,620 | 2.85M |
| 493 | ICU | SeaStar Medical Holding Corporation | 14.86M | 2.76% | 544,605 | 1.23M |
| 494 | INAB | IN8bio, Inc. | 14.57M | 8.03% | 72,870 | - |
| 495 | PHIO | Phio Pharmaceuticals Corp. | 14.17M | 1.67% | 205,790 | - |
| 496 | COCP | Cocrystal Pharma, Inc. | 13.92M | 1.00% | 22,463 | - |
| 497 | HOTH | Hoth Therapeutics, Inc. | 13.66M | 9.12% | 118,368 | - |
| 498 | BCAB | BioAtla, Inc. | 13.34M | 4.55% | 1,412,473 | 11.00M |
| 499 | BCDA | BioCardia, Inc. | 13.24M | 4.31% | 28,538 | 3.00K |
| 500 | JUNS | Jupiter Neurosciences, Inc. | 12.95M | 15.83% | 34,552 | - |